Search

Marianne P. Allen

Examiner (ID: 17617, Phone: (571)272-0712 , Office: P/1647 )

Most Active Art Unit
1647
Art Unit(s)
1818, 1812, 1645, 1805, 1631, 1647
Total Applications
2168
Issued Applications
1046
Pending Applications
251
Abandoned Applications
885

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5409571 [patent_doc_number] => 20090123469 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Anti-factor B antibodies and their uses' [patent_app_type] => utility [patent_app_number] => 12/291222 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17601 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123469.pdf [firstpage_image] =>[orig_patent_app_number] => 12291222 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/291222
Anti-factor B antibodies and their uses Nov 5, 2008 Issued
Array ( [id] => 5533047 [patent_doc_number] => 20090232835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'Composition for delivery of hematopoietic growth factor' [patent_app_type] => utility [patent_app_number] => 12/291344 [patent_app_country] => US [patent_app_date] => 2008-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9556 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20090232835.pdf [firstpage_image] =>[orig_patent_app_number] => 12291344 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/291344
Composition for delivery of hematopoietic growth factor Nov 5, 2008 Abandoned
Array ( [id] => 5422488 [patent_doc_number] => 20090148943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'AGENT FOR ENHANCING THE PRODUCTION OF CYTOKINES AND/OR CHEMOKINES' [patent_app_type] => utility [patent_app_number] => 12/265348 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8658 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20090148943.pdf [firstpage_image] =>[orig_patent_app_number] => 12265348 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/265348
AGENT FOR ENHANCING THE PRODUCTION OF CYTOKINES AND/OR CHEMOKINES Nov 4, 2008 Abandoned
Array ( [id] => 9020633 [patent_doc_number] => 08530619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Identification of the hepcidin binding site on ferroportin' [patent_app_type] => utility [patent_app_number] => 12/734061 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 24 [patent_no_of_words] => 10043 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12734061 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/734061
Identification of the hepcidin binding site on ferroportin Oct 26, 2008 Issued
Array ( [id] => 6196928 [patent_doc_number] => 20110028686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Protein binding miniature proteins' [patent_app_type] => utility [patent_app_number] => 12/288401 [patent_app_country] => US [patent_app_date] => 2008-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 37458 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028686.pdf [firstpage_image] =>[orig_patent_app_number] => 12288401 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/288401
Protein binding miniature proteins Oct 19, 2008 Abandoned
Array ( [id] => 6615317 [patent_doc_number] => 20100310548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'Methods of Manufacturing a Biologic Using a Stable Storage Intermediate' [patent_app_type] => utility [patent_app_number] => 12/738091 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 19089 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310548.pdf [firstpage_image] =>[orig_patent_app_number] => 12738091 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738091
Methods of Manufacturing a Biologic Using a Stable Storage Intermediate Oct 14, 2008 Abandoned
Array ( [id] => 6266498 [patent_doc_number] => 20100298236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'SOLUBLE GP130 MUTEINS WITH IMPROVED BINDING ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/738807 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9444 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298236.pdf [firstpage_image] =>[orig_patent_app_number] => 12738807 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/738807
Soluble GP130 muteins with improved binding activity Oct 14, 2008 Issued
Array ( [id] => 5380240 [patent_doc_number] => 20090192079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'PROLONGED DELIVERY OF HEPARIN-BINDING GROWTH FACTORS FROM HEPARIN-DERIVATIZED COLLAGEN' [patent_app_type] => utility [patent_app_number] => 12/248307 [patent_app_country] => US [patent_app_date] => 2008-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6081 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20090192079.pdf [firstpage_image] =>[orig_patent_app_number] => 12248307 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/248307
PROLONGED DELIVERY OF HEPARIN-BINDING GROWTH FACTORS FROM HEPARIN-DERIVATIZED COLLAGEN Oct 8, 2008 Abandoned
Array ( [id] => 6054596 [patent_doc_number] => 20110110956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Heparin-Binding Epidermal Growth Factor-like Growth Factor Binding Proteins' [patent_app_type] => utility [patent_app_number] => 12/680191 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 233 [patent_figures_cnt] => 233 [patent_no_of_words] => 53240 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110956.pdf [firstpage_image] =>[orig_patent_app_number] => 12680191 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/680191
Heparin-binding epidermal growth factor-like growth factor binding proteins Sep 25, 2008 Issued
Array ( [id] => 5429163 [patent_doc_number] => 20090088473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'METHOD FOR SCREENING OF PROSTAGLANDIN COMPOUNDS COMPRISING AN OPTIMAL FORMULATION FOR THE ENHANCEMENT OF HAIR GROWTH AND THE STIMULATION OF FOLLICULAR ANAGEN AND FORMULATIONS RESULTING THEREFROM' [patent_app_type] => utility [patent_app_number] => 12/239237 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1900 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20090088473.pdf [firstpage_image] =>[orig_patent_app_number] => 12239237 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/239237
METHOD FOR SCREENING OF PROSTAGLANDIN COMPOUNDS COMPRISING AN OPTIMAL FORMULATION FOR THE ENHANCEMENT OF HAIR GROWTH AND THE STIMULATION OF FOLLICULAR ANAGEN AND FORMULATIONS RESULTING THEREFROM Sep 25, 2008 Abandoned
Array ( [id] => 6506258 [patent_doc_number] => 20100210520 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-08-19 [patent_title] => 'REGULATION OF FUNCTION OF ANGIOPOIETIN' [patent_app_type] => utility [patent_app_number] => 12/211073 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15090 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0210/20100210520.pdf [firstpage_image] =>[orig_patent_app_number] => 12211073 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/211073
REGULATION OF FUNCTION OF ANGIOPOIETIN Sep 14, 2008 Abandoned
Array ( [id] => 6506258 [patent_doc_number] => 20100210520 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2010-08-19 [patent_title] => 'REGULATION OF FUNCTION OF ANGIOPOIETIN' [patent_app_type] => utility [patent_app_number] => 12/211073 [patent_app_country] => US [patent_app_date] => 2008-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15090 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0210/20100210520.pdf [firstpage_image] =>[orig_patent_app_number] => 12211073 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/211073
REGULATION OF FUNCTION OF ANGIOPOIETIN Sep 14, 2008 Abandoned
Array ( [id] => 6070670 [patent_doc_number] => 20110045520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'FATTY ACID MARKERS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF CARDIOVASCULAR DISEASE' [patent_app_type] => utility [patent_app_number] => 12/674765 [patent_app_country] => US [patent_app_date] => 2008-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7600 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20110045520.pdf [firstpage_image] =>[orig_patent_app_number] => 12674765 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/674765
FATTY ACID MARKERS FOR THE DIAGNOSIS, PROGNOSIS AND MANAGEMENT OF CARDIOVASCULAR DISEASE Sep 11, 2008 Abandoned
Array ( [id] => 5279197 [patent_doc_number] => 20090131329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Treatment for allograft rejection' [patent_app_type] => utility [patent_app_number] => 12/283246 [patent_app_country] => US [patent_app_date] => 2008-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6280 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131329.pdf [firstpage_image] =>[orig_patent_app_number] => 12283246 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/283246
Treatment for allograft rejection Sep 9, 2008 Abandoned
Array ( [id] => 6349236 [patent_doc_number] => 20100249019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'USE OF A PEPTIDE AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677805 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36441 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249019.pdf [firstpage_image] =>[orig_patent_app_number] => 12677805 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677805
USE OF A PEPTIDE AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 6231574 [patent_doc_number] => 20100184708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'USE OF GLY-PRO-GLU-OH (GPE) AS A THERAPEUTIC AGENT' [patent_app_type] => utility [patent_app_number] => 12/677812 [patent_app_country] => US [patent_app_date] => 2008-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33413 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184708.pdf [firstpage_image] =>[orig_patent_app_number] => 12677812 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/677812
USE OF GLY-PRO-GLU-OH (GPE) AS A THERAPEUTIC AGENT Sep 8, 2008 Abandoned
Array ( [id] => 4759913 [patent_doc_number] => 20080312139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Use of Pharmaceutical Composition Containing Epidermal Growth Factor (EGF) for Diabetic foot Amputation Prevention' [patent_app_type] => utility [patent_app_number] => 12/197001 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4382 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20080312139.pdf [firstpage_image] =>[orig_patent_app_number] => 12197001 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/197001
Use of pharmaceutical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention Aug 21, 2008 Issued
Array ( [id] => 5297340 [patent_doc_number] => 20090012266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Anti-TNFalpha Antibodies and Methods of Use' [patent_app_type] => utility [patent_app_number] => 12/189237 [patent_app_country] => US [patent_app_date] => 2008-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5157 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012266.pdf [firstpage_image] =>[orig_patent_app_number] => 12189237 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/189237
Anti-TNFα antibodies and methods of use Aug 10, 2008 Issued
Array ( [id] => 5496342 [patent_doc_number] => 20090264370 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2009-10-22 [patent_title] => 'POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1' [patent_app_type] => utility [patent_app_number] => 12/189012 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38459 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0264/20090264370.pdf [firstpage_image] =>[orig_patent_app_number] => 12189012 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/189012
POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 Aug 7, 2008 Abandoned
Array ( [id] => 5496342 [patent_doc_number] => 20090264370 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2009-10-22 [patent_title] => 'POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1' [patent_app_type] => utility [patent_app_number] => 12/189012 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38459 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A9/0264/20090264370.pdf [firstpage_image] =>[orig_patent_app_number] => 12189012 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/189012
POLYPEPTIDES HOMOLOGOUS TO VEGF AND BMP1 Aug 7, 2008 Abandoned
Menu